{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-076043","form_type":"8-K","ticker":"TKNO","cik":"0001850902","company_name":"Alpha Teknova, Inc.","filed_at":"2022-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.844818+00:00","generated_at":"2026-06-26T22:56:38.451750+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Teknova FY2021 revenue $36.9M (+18% YoY); net loss $9.8M vs $0.6M income in 2020","bullets":["FY2021 total revenue $36.9M, up 18% YoY; ex-Sample Transport $35.4M, up 31% YoY.","Q4 2021 total revenue $10.1M flat; ex-Sample Transport $9.6M, up 26% YoY.","FY2021 net loss $9.8M ($0.61 loss/diluted share) vs net income $0.6M ($0.16 EPS) in 2020.","Q4 2021 net loss $3.6M ($0.13 loss/diluted share) vs net income $0.1M ($0.03 EPS) in Q4 2020.","2022 revenue guidance $44-$48M; expects 25% growth in Lab Essentials, 60% in Clinical Solutions; no Sample Transport."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-076043","json":"https://secwatch.observer/filing/0001193125-22-076043.json","markdown":"https://secwatch.observer/filing/0001193125-22-076043.md","text":"https://secwatch.observer/filing/0001193125-22-076043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850902/000119312522076043/0001193125-22-076043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850902/000119312522076043/d336287d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T22:56:38.451750+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}